If we’ve learned anything in the last three years, it’s that the only reasonable prediction is more unpredictability. Undaunted by this reality, life sciences market experts from Optum and Advisory Board came together once again to find signal in the noise – offering our take on 7 trends shaping life sciences strategies in 2023.

Rooted in conversations with over one-hundred evidence-generators, data scientists, researchers, clinicians, and decision-makers across the health care ecosystem, the insights and recommendations captured here are intended to provoke thought, challenge conventional wisdom, and stimulate the kinds of cross-functional conversations that can catalyze meaningful industry change.

Read more to:

• See what we’ve identified as the trends most likely to shape life sciences leaders’ real-world data (RWD)/real-world evidence (RWE), market access, and customer engagement strategies in the year ahead
• Consider the implications of these trends on different stakeholders within the health care ecosystem
• Gather ideas for thoughtful questions to ground strategic planning meetings with your team, with cross-functional colleagues, and with important business partners
• Challenge your own assumptions. Or challenge ours. We’d welcome the conversation